EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALL

Tamer Othman, Aaron C Logan, Lori Muffly, Jessica Leonard, Jae Park, Bijal Shah, Ibrahim Aldoss

Journal of the National Comprehensive Cancer Network · 2024-10 · 22 (8)

DOI: 10.6004/jnccn.2024.7065 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024-10. Verfasst von Tamer Othman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 87 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CAR T-cell therapy is a recent therapeutic advancement that has transformed the management of relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL). To date, there are 2 FDA-approved CAR-T products for R/R B-ALL: tisagenlecleucel in patients aged

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveReceptors, Chimeric AntigenHumansAdultPrecursor B-Cell Lymphoblastic Leukemia-LymphomaReceptors, Antigen, T-CellTreatment OutcomeClinical Trials as TopicNeoplasm Recurrence, Local

Substanzen

Receptors, Chimeric AntigenReceptors, Antigen, T-Celltisagenlecleucel

Autor:innen und Institutionen

  • Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.
  • Division of Hematology and Blood and Marrow Transplantation, Department of Medicine, University of California, San Francisco, San Francisco, CA.
  • Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
  • Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR.
  • Department of Medicine, Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

Zitieren

APA

Othman, T., Logan, A. C., Muffly, L., Leonard, J., Park, J., Shah, B., & Aldoss, I. (2024). The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALL. Journal of the National Comprehensive Cancer Network, 22(8). https://doi.org/10.6004/jnccn.2024.7065

Vancouver

Othman T, Logan AC, Muffly L, Leonard J, Park J, Shah B, et al. The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALL. Journal of the National Comprehensive Cancer Network. 2024;22(8). doi:10.6004/jnccn.2024.7065

BibTeX
@article{Othman2024,
  author = {Othman, Tamer and Logan, Aaron C and Muffly, Lori and Leonard, Jessica and Park, Jae and Shah, Bijal and Aldoss, Ibrahim},
  title = {The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALL},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2024},
  volume = {22},
  number = {8},
  doi = {10.6004/jnccn.2024.7065}
}
Kostenlos starten →